BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3530566)

  • 21. [Scleroderma renal crisis. 7 cases and review of the literature].
    Bonnet F; Longy-Boursier M; Aparicio M; Morlat P; Doutre MS; Conri C; Pellegrin JL; Leng B; Mercie P
    Ann Med Interne (Paris); 1998 Sep; 149(5):243-50. PubMed ID: 9791556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
    Luft FC; Aronoff GR; Evan AP; Connors BA; Weinberger MH; Kleit SA
    J Pharmacol Exp Ther; 1982 Feb; 220(2):433-9. PubMed ID: 6276536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)].
    El Matri A; Kechrid C; Larabi M; Belkahia C; Ben Ayed H
    Nouv Presse Med; 1981 Apr; 10(19):1575-8. PubMed ID: 7025848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term treatment with captopril in arterial hypertension complicated by renal failure].
    Durand D; Ader JL; Emal V; Bories P; Girolami JP; Suc JM
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():151-6. PubMed ID: 6126168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylaxis of bone marrow transplant nephropathy with captopril, an inhibitor of angiotensin-converting enzyme.
    Moulder JE; Cohen EP; Fish BL; Hill P
    Radiat Res; 1993 Dec; 136(3):404-7. PubMed ID: 8278583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
    Rasmussen S; Ibsen H; Giese J
    Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Renal crisis in scleroderma with normal blood pressure].
    Asali A; Shoenfeld Y
    Harefuah; 1990 Mar; 118(6):319-20. PubMed ID: 2347533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute renal insufficiency following inhibition of the angiotensin conversion enzyme by various agents].
    Bussien JP; Schaller MD; Nussberger J; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1984 Feb; 114(7):236-9. PubMed ID: 6322293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scleroderma renal crisis: patient characteristics and long-term outcomes.
    Penn H; Howie AJ; Kingdon EJ; Bunn CC; Stratton RJ; Black CM; Burns A; Denton CP
    QJM; 2007 Aug; 100(8):485-94. PubMed ID: 17601770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis, management and prevention of scleroderma renal disease.
    Penn H; Denton CP
    Curr Opin Rheumatol; 2008 Nov; 20(6):692-6. PubMed ID: 18946330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney crisis in systemic sclerosis.
    Lewandowski B; Domysławska I; Klimiuk PA; Sierakowski S
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():294-6. PubMed ID: 16119690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renal insufficiency after administration of captopril in renal artery stenosis with a single kidney or bilateral stenosis is not compulsory].
    Durand D; Tran Van T; Ader JL; Suc JM
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1272-7. PubMed ID: 6441547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scleroderma crisis: progressive renal failure despite blood-pressure control.
    DiPette DJ; Daisley SJ; Fragola JA
    Clin Pharm; 1983; 2(2):179-81. PubMed ID: 6349906
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progressive reversible kidney insufficiency after blood pressure reduction with captopril].
    Kindler J; Konrads A; Meurer KA; Sieberth HG
    Internist (Berl); 1981 Jun; 22(6):360-3. PubMed ID: 6265394
    [No Abstract]   [Full Text] [Related]  

  • 40. Longterm survival after renal crisis.
    Fries JF
    J Rheumatol; 1990 Nov; 17(11):1572-3. PubMed ID: 2273515
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.